Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +1.75% | +11.54% | -30.95% |
Mar. 29 | First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.77M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.58
x | P/E ratio 2025 * |
-1.84
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.31% |
1 day | +1.06% | ||
1 week | +9.62% | ||
Current month | +7.95% | ||
1 month | -14.16% | ||
3 months | -48.09% | ||
6 months | -48.44% | ||
Current year | -32.14% |
Managers | Title | Age | Since |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 19-10-07 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 22-02-28 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-03-02 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 15-04-30 |
Alastair Riddell
BRD | Director/Board Member | 74 | 15-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 2.9 | +1.75% | 10 940 |
24-05-10 | 2.85 | +1.06% | 26,775 |
24-05-09 | 2.82 | +1.44% | 5,232 |
24-05-08 | 2.78 | +5.30% | 45,411 |
24-05-07 | 2.64 | +1.54% | 14,867 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.14% | 5.77M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+47.47% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- FWBI Stock